Influence of atorvastatin to sICAM-1,sVCAM-1 and PAI-1 in acute coronary syndrome patients receiving percutaneous coronary intervention

›› 2010, Vol. 25 ›› Issue (07): 553-556.

• 论文 • Previous Articles Next Articles

Influence of atorvastatin to sICAM-1,sVCAM-1 and PAI-1 in acute coronary syndrome patients receiving percutaneous coronary intervention

LIU Xuejun;LIU Yue

Received:2010-07-01 Online:2010-07-01 Published:2010-07-01

Abstract

CLC Number:

R466.11

LIU Xuejun;LIU Yue. Influence of atorvastatin to sICAM-1,sVCAM-1 and PAI-1 in acute coronary syndrome patients receiving percutaneous coronary intervention [J]. , 2010, 25(07): 553-556.

[1]	TANG Jibin, HU Zhijun, ZHANG Sheng, JIAO Ruibao.. Surveillance analysis on bacterial drug resistance at Tongling in 2014 [J]. Laboratory Medicine, 2015, 30(8): 798-803.
[2]	. [J]. , 2011, 26(11): 783-790.
[3]	. [J]. , 2011, 26(11): 783-790.
[4]	HE Yinhua;YAN Yufei;CAI Zheng;JIN Ligang. Evaluation of automatic hematology analyzer Sysmex XE-2100 for counting nucleated cells in hydrothorax and ascite fluid [J]. , 2011, 26(04): 228-230.
[5]	WU Baiqing;CHEN Shilin;ZHANG Shuisheng. The morphocytology observation on FAB and WHO typing in 112 patients with myelodysplastic syndrome [J]. , 2010, 25(08): 612-614.
[6]	. [J]. , 2005, 20(01): 66-67.

Influence of atorvastatin to sICAM-1,sVCAM-1 and PAI-1 in acute coronary syndrome patients receiving percutaneous coronary intervention

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 6

Recommended Articles

Metrics